Evidence map›Paper›PMID 22711303›Full record

ArticleMolecular biology reports2012

Partial antiviral activities of the Asn631 chicken Mx against newcastle disease virus and vesicular stomatitis virus.

Bichun Li, Dezhi Fu, Yani Zhang, Qi Xu, Ligang Ni, Guobin Chang, Mengmeng Zheng, Bo Gao, Huaichang Sun, Guohong Chen

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Mx proteins: antiviral gatekeepers that restrain the uninvited.Microbiology and molecular biology reviews : MMBR · 2013
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Bichun LiCollege of Animal Science and Technology, Yangzhou University, Yangzhou 225009, People's Republic of China. yubcli@yzu.edu.cn
Dezhi Fu
Yani Zhang
Qi Xu
Ligang Ni
Guobin Chang
Mengmeng Zheng
Bo Gao
Huaichang Sun
Guohong Chen

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Conflicting data existed for the antiviral potential of the chicken Mx protein and the importance of the Asn631 polymorphism in determination of the antiviral activity. In this study we modified the chicken Mx cDNA from the Ser631 to Asn631 genotype and transfected them into COS-I cells, chicken embryonic fibroblast (CEF) or NIH 3T3 cells. The Mx protein was mainly located at the cytoplasm. The transfected cell cultures were challenged with newcastle disease virus (NDV) or vesicular stomatitis virus (VSV), cytopathic affect (CPE) inhibition assay showed that the times for development of visible and full CPE were significantly postponed by the Asn631 cDNA transfection at 48 h transfection, but not by the Ser631 cDNA transfection. Viral titration assay showed that the virus titers were significantly reduced before 72 h postinfection. CEF cells was incubated by the cell lysates extracted from the COS-I cells transfected with pcDNA-Mx/Asn631, could resist and delayed NDV infection. These data suggested the importance of the Asn631 polymorphism of the chicken Mx in determination of the antiviral activities against NDV and VSV at early stage of viral infection, which were relatively weak and not sufficient to inhibit the viral replication at late stage of viral infection.

Indexed as

AnimalsAntiviral AgentsChickensChlorocebus aethiopsCOS CellsCytopathogenic Effect, ViralDNA, ComplementaryGene ExpressionGTP-Binding ProteinsMiceMutationMyxovirus Resistance ProteinsNewcastle disease virusNIH 3T3 CellsRecombinant ProteinsTransfectionAntiviral AgentsDNA, ComplementaryGTP-Binding ProteinsMx1 protein, mouseMyxovirus Resistance ProteinsRecombinant Proteins

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.